WSJ Reports That IBM Developed New Drug That Could Reduce MRSA

As reported in today's Wall Street Journal

International Business Machines Corp.  said they developed a tiny drug, called a nanoparticle, that in test-tube experiments showed promise as a weapon against dangerous superbugs that have become resistant to antibiotics.Their researchers, in collaboration with scientists at the Institute of Bioengineering and Nanotechnology, Singapore, said their nanoparticle can target and destroy antibiotic-resistant bacteria—such as the potentially lethal Methicillin-resistant Staphylococcus aureus, or MRSA—without affecting healthy cells. 

to read the full coverage please visit www.wsjonline.com.